Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice on Full-Year Business Results Forecasts
Perseus Proteomics, The Current Fiscal Year's Undisclosed Net Income to Narrow
PPMX-T003: Notice on Completion of Clinical Study Report of Phase I Clinical Trial among Polycythemia Vera Patients
(Amendment) Amendment to "PPMX-T003: Selection as FY2026/3 Project Promoting Support for Drug Discovery Support Program for Orphan drug prior to the
PPMX-T003: Selection as FY2026/3 Project Promoting Support for Drug Discovery Support Program for Orphan drug prior to the Designation by AMED
Perseus Proteomics, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Notice on Recording of Non-operating Income, Non-operating Expenses, and Extraordinary Losses
Non-consolidated Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2025
PPMX-T003: Announcement on Extension of Investigator-led Phase I/II Clinical Trial for Aggressive NK-cell Leukemia (ANKL)
Announcement of Presentation of PPMX-T003 Phase I of Polycythemia Vera at 66th ASH Annual Meeting and Exposition
Presentation Material for FY2025/3 First Half Business Results
Notice on Recording of Non-operating Income, Non-operating Expenses, and Extraordinary Losses
Non-consolidated Summary of Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2025
Perseus Proteomics Inc., July-September (2Q) Net Income Loss Widens
Announcement of Sales Launch of New Antibody/Reagent
Announcement of Presentation of PPMX-T003 Phase I at 66th ASH Annual Meeting and Exposition
Announcement of Presentation of PPMX-T002 at EANM’24 Annual Congress
Perseus Proteomics and UBE Sign a Collaborative Research Agreement on Antibody-Drug Conjugates (ADC)
Perseus Proteomics Participating in Japan Healthcare Venture Summit 2024
Announcement of Abstract of PPMX-T002 Presentation at EANM'24 Annual Congress